Low immunity against vaccine preventable diseases in Turkish HIV cohort

Background/aim: HIV infection increase the risk of serious disease resulting from common vaccine-preventable infections. Vaccinations are particularly important for HIV infected adults. We aimed to investigate the immunity rates against measles, mumps, rubella, hepatitis A, B, and tetanus in newly diagnosed HIV patients. Materials and methods: Patients who admitted to outpatient clinics of three centers with newly diagnosed HIV infection, between 1 January 2015 and 31 June 2017 were included. Measles, mumps, rubella, varicella zoster virus, hepatitis A, hepatitis B, and tetanus antibody levels were measured by commercial diagnostic kits. Demographical and laboratory data of the patients were recorded. Results: Five hundred and twenty-three patients were enrolled in the study. Of the patients 87% were male (n = 455) and the mean age was 38 ± 13 years. Serology was available for measles 74.2% (388/523), mumps 73.8% (386/523), rubella 77.8% (407/523), hepatitis A 88.5% (463/523), hepatitis B 97.7% (511/523), tetanus 8.6% (45/523), and VZV 79.9% (418/523). Seropositivity was 82% for measles, 75.6% for mumps, 92.1% for rubella. Of the patients whom all three of the components of the MMR vaccine was tested, 37.7% (127/337) were susceptible at least one and needed the vaccine. Mean age was lower in patients who are nonimmune to measles and mumps (p = 0.008). Younger patients were also nonimmune for hepatitis A, while older patients were nonimmune for hepatitis B. Conclusion: In our study we found that rates of nonimmunity can increase up to one third of the patients even though there is a national vaccination program. Nonimmune individuals should be detected and vaccinated in line with recent guidelines and response should be monitored because of the possibility of impaired immunity and possible suboptimal response. National campaigns can be launched for adult immunization and physicians should be aware of the importance of adult immunization.Key words: HIV, immunity, measles, mumps, rubella, tetanus

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nature Reviews Disease Primers 2015; 1 (1): 15035. doi: 10.1038/nrdp.2015.35
2. Molton J, Smith C, Chaytor S, Maple P, Brown K et al. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. Journal of Infection 2010; 61 (1): 73-80. doi: 10.1016/j.jinf.2010.04.004
3. Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care and STDs 2014; 28 (8): 397-410. doi: 10.1089/apc.2014.0121
4. Kernéis S, Launay O, Turbelin C, Batteux F, Hanslik T et al. Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. Clinical Infectious Diseases 2014; 58 (8): 1130-1139. doi: 10.1093/cid/ cit937
5. Ehren K, Hertenstein C, Kümmerle T, Vehreschild JJ, Fischer J et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection 2014; 42 (1): 135-140. doi: 10.1007/s15010-013-0535-7
6. Kemper CA, Gangar M, Arias G, Kane C, Deresinski SC. The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California. Journal of Infectious Disesases 1998; 178 (4): 1177-1180. doi: 10.1086/515679
7. Kemper CA, Zolopa AR, Hamilton JR, Fenstersheib M, Bhatia G et al. Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity. AIDS 1992; 6 (11): 1321-1325. doi: 10.1097/00002030-199211000- 00013
8. Choudhury SA, Hatcher F, Berthaud V, Ladson G, Hills E et al. Immunity to measles in pregnant mothers and in cord blood of their infants: impact of HIV status and mother’s place of birth. Journal of the National Medical Association 2008; 100 (12): 1445-1449. doi: 10.1016/s0027-9684(15)31545-5
9. Lambert D, Dramé M, Rouger C, Brodard V, Nguyen Y et al. High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France. AIDS 2015; 29 (2): 241-243. doi: 10.1097/ QAD.0000000000000549
10. Llenas-García J, Rubio R, Hernando A, Arrazola P, Pulido F. Do HIV-positive adult immigrants need to be screened for measlesmumps-rubella and varicella zoster virus immunization? AIDS Care 2013; 25 (8): 980-989. doi: 10.1080/09540121.2012.748881
11. Grabmeier-Pfistershammer K, Poeppl W, Herkner H, TouzeauRoemer V, Huschka E et al. High need for MMR vaccination in HIV infected adults in Austria. Vaccine 2014; 32 (45): 6020- 6023. doi: 10.1016/j.vaccine.2014.07.114
12. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B et al. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360 (9349): 1921-1926. doi: 10.1016/ s0140-6736(02)11913-1
13. Costa-Mattioli M, Allavena C, Poirier AS, Billaudel S, Raffi F et al. Prolonged hepatitis A infection in an HIV-1 seropositive patient. Journal of Medical Virology 2002; 68 (1): 7-11. doi: 10.1002/jmv.10163
14. Veenstra J, Van Praag RM, Krol A, Wertheim van Dillen PM, Weigel HM et al. Complications of varicella zoster virus reactivation in HIV-infected homosexual men. AIDS 1996; 10 (4): 393-399. doi: 10.1097/00002030-199604000-00007
15. Gebo KA, Kalyani R, Moore RD, Polydefkis MJ. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. Journal of Acquired Immune Deficiency Syndromes 2005; 40 (2): 169- 174. doi: 10.1097/01.qai.0000178408.62675.b0
16. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267 (9): 1237- 1241.
17. Crum-Cianflone NF, Sullivan E. Vaccinations for the HIVinfected adult: a review of the current recommendations, part I. Infectious Diseases and Therapy 2017; 6 (3): 303-331. doi: 10.1007/s40121-017-0166-x
18. Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? Journal of Infection and Public Health 2012; 5 (2): 127-132. doi: 10.1016/j.jiph.2011.11.003
19. Aypak C, Bayram Y, Eren H, Altunsoy A, Berktaş M. Susceptibility to measles, rubella, mumps, and varicella-zoster viruses among healthcare workers. Journal of Nippon Medical School 2012; 79 (6): 453-458. doi: 10.1272/jnms.79.453
20. Cılız N, Gazi H, Ecemiş T, Şenol Ş, Akçalı S et al. Sağlık çalışanlarında Kızamık, Kızamıkçık, Kabakulak, Suçiçeği, Difteri, Tetanos ve Hepatit B Seroprevalansı. Klimik Dergisi 2013; 26 (1): 26-30 (in Turkish). doi: 10.5152/kd.2013.07
21. Çalık Ş, Tosun S, Tuncel Başoğlu M, Sayın S. The Investigation of Seroprevalence of Measles, Rubella, Mumps, and Varicella in Medical Students. FLORA 2017; 22 (2): 73-77 (in Turkish). doi: 10.5578/flora.61879
22. Dilli D, Dallar Y, Önde U, Doğan F, Yağcı S. Ergenlerde kızamık, kızamıkçık, kabakulak ve su çiçeği prevalansı. Çocuk Dergisi 2008; 8 (3): 172-178 (in Turkish).
23. Köse Ş, Mandiracıoğlu A, Egemen A. Erişkinlerde kızamık antikor seropozitifliğinin değerlendirilmesi. Ege Tıp Dergisi 2006; 45 (2): 93-95 (in Turkish).
24. Guclu E, Ogutlu A, Karabay O. A Study on the age-related changes in hepatitis B and C virus serology. The Eurasian Journal of Medicine 2016; 48 (1): 37-41. doi: 10.5152/ eurasianjmed.2015.85
25. Emek M, Islek D, Atasoylu G, Ozbek OA, Ceylan A et al. Association between seroprevalence of measles and various social determinants in the year following a measles outbreak in Turkey. Public Health 2017; 147: 51-58. doi: 10.1016/j. puhe.2017.01.026
26. Tanriover MD, Soyler C, Ascioglu S, Cankurtaran M, Unal S. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. European Journal of Internal Medicine 2014; 25 (6): 528-532. doi: 10.1016/j.ejim.2014.04.010
27. Kose S, Mandiracioglu A, Senger SS, Ulu Y, Cavdar G et al. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey. J Infection and Public Health 2013; 6 (2): 115-119. doi: 10.1016/j.jiph.2012.10.003
28. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clinical Microbiology and Infection 2015; 21 (11): 1020-1026. doi: 10.1016/j.cmi.2015.06.028
29. Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G et al. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine 2018; 36 (12): 1664-1672. doi: 10.1016/j.vaccine.2018.01.079
30. Ceran N, Yüksel Kocdogan F, Mert D, Erdem I, Dede B et al. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. Journal of Viral Hepatitis 2012; 19 (1): 72-76. doi: 10.1111/j.1365-2893.2011.01454.x
31. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. The Pediatric Infectious Diseases Journal 1992; 11 (12): 1008-1014. doi: 10.1097/00006454-199211120-00004
32. Fine PE. Herd immunity: history, theory, practice. Epidemiologic Reviews 1993; 15 (2): 265-302. doi: 10.1093/ oxfordjournals.epirev.a036121
33. Frésard A, Gagneux-Brunon A, Lucht F, Botelho-Nevers E, Launay O. Immunization of HIV-infected adult patients - French recommendations. Human Vaccines & Immunotherapeutics 2016; 12 (11): 2729-2741. doi: 10.1080/21645515.2016.1207013
34. Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH et al. Shingles prevention study group. Long-term persistence of zoster vaccine efficacy. Clinical Infectious Diseases 2015; 60 (6): 900-909. doi: 10.1093/cid/ciu918
35. Crum-Cianflone NF, Sullivan E. Vaccinations for the HIVinfected adult: a review of the current recommendations, part II. Infectious Diseases and Therapy 2017; 6 (3): 333-361. doi: 10.1007/s40121-017-0165-y
36. Molton J, Smith C, Chaytor S, Maple P, Brown K et al. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. Journal of Infection 2010; 61 (1): 73-80. doi: 10.1016/j.jinf.2010.04.004
37. Valour F, Cotte L, Voirin N, Godinot M, Ader F et al. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1) 2009 pandemic influenza in HIV-infected patients. Vaccine 2014; 32 (35): 4558-4564. doi: 10.1016/j.vaccine.2014.06.015
38. Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB et al. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. Vaccine 2015; 33 (38): 4938-4944. doi: 10.1016/j.vaccine.2015.07.036
39. Grabmeier-Pfistershammer K, Herkner H, Touzeau-Roemer V, Rieger A, Burgmann H et al. Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine 2015; 33 (32): 3929- 3932. doi: 10.1016/j.vaccine.2015.06.056

APA	Candevir A, Kuscu F, Sarıgül F, komur s, ÇİÇEK ŞENTÜRK G, INAL A, eser f, ÇETINER S, Kurtaran B, TASOVA Y (2021). Low immunity against vaccine preventable diseases in Turkish HIV cohort. , 2311 - 2317. 10.3906/sag-2102-14
Chicago	Candevir Aslıhan,Kuscu Ferit,Sarıgül Figen,komur suheyla,ÇİÇEK ŞENTÜRK Gönül,INAL AYSE SEZA,eser fatma,ÇETINER SALIH,Kurtaran Behice,TASOVA YESIM Low immunity against vaccine preventable diseases in Turkish HIV cohort. (2021): 2311 - 2317. 10.3906/sag-2102-14
MLA	Candevir Aslıhan,Kuscu Ferit,Sarıgül Figen,komur suheyla,ÇİÇEK ŞENTÜRK Gönül,INAL AYSE SEZA,eser fatma,ÇETINER SALIH,Kurtaran Behice,TASOVA YESIM Low immunity against vaccine preventable diseases in Turkish HIV cohort. , 2021, ss.2311 - 2317. 10.3906/sag-2102-14
AMA	Candevir A,Kuscu F,Sarıgül F,komur s,ÇİÇEK ŞENTÜRK G,INAL A,eser f,ÇETINER S,Kurtaran B,TASOVA Y Low immunity against vaccine preventable diseases in Turkish HIV cohort. . 2021; 2311 - 2317. 10.3906/sag-2102-14
Vancouver	Candevir A,Kuscu F,Sarıgül F,komur s,ÇİÇEK ŞENTÜRK G,INAL A,eser f,ÇETINER S,Kurtaran B,TASOVA Y Low immunity against vaccine preventable diseases in Turkish HIV cohort. . 2021; 2311 - 2317. 10.3906/sag-2102-14
IEEE	Candevir A,Kuscu F,Sarıgül F,komur s,ÇİÇEK ŞENTÜRK G,INAL A,eser f,ÇETINER S,Kurtaran B,TASOVA Y "Low immunity against vaccine preventable diseases in Turkish HIV cohort." , ss.2311 - 2317, 2021. 10.3906/sag-2102-14
ISNAD	Candevir, Aslıhan vd. "Low immunity against vaccine preventable diseases in Turkish HIV cohort". (2021), 2311-2317. https://doi.org/10.3906/sag-2102-14

APA	Candevir A, Kuscu F, Sarıgül F, komur s, ÇİÇEK ŞENTÜRK G, INAL A, eser f, ÇETINER S, Kurtaran B, TASOVA Y (2021). Low immunity against vaccine preventable diseases in Turkish HIV cohort. Turkish Journal of Medical Sciences, 51(5), 2311 - 2317. 10.3906/sag-2102-14
Chicago	Candevir Aslıhan,Kuscu Ferit,Sarıgül Figen,komur suheyla,ÇİÇEK ŞENTÜRK Gönül,INAL AYSE SEZA,eser fatma,ÇETINER SALIH,Kurtaran Behice,TASOVA YESIM Low immunity against vaccine preventable diseases in Turkish HIV cohort. Turkish Journal of Medical Sciences 51, no.5 (2021): 2311 - 2317. 10.3906/sag-2102-14
MLA	Candevir Aslıhan,Kuscu Ferit,Sarıgül Figen,komur suheyla,ÇİÇEK ŞENTÜRK Gönül,INAL AYSE SEZA,eser fatma,ÇETINER SALIH,Kurtaran Behice,TASOVA YESIM Low immunity against vaccine preventable diseases in Turkish HIV cohort. Turkish Journal of Medical Sciences, vol.51, no.5, 2021, ss.2311 - 2317. 10.3906/sag-2102-14
AMA	Candevir A,Kuscu F,Sarıgül F,komur s,ÇİÇEK ŞENTÜRK G,INAL A,eser f,ÇETINER S,Kurtaran B,TASOVA Y Low immunity against vaccine preventable diseases in Turkish HIV cohort. Turkish Journal of Medical Sciences. 2021; 51(5): 2311 - 2317. 10.3906/sag-2102-14
Vancouver	Candevir A,Kuscu F,Sarıgül F,komur s,ÇİÇEK ŞENTÜRK G,INAL A,eser f,ÇETINER S,Kurtaran B,TASOVA Y Low immunity against vaccine preventable diseases in Turkish HIV cohort. Turkish Journal of Medical Sciences. 2021; 51(5): 2311 - 2317. 10.3906/sag-2102-14
IEEE	Candevir A,Kuscu F,Sarıgül F,komur s,ÇİÇEK ŞENTÜRK G,INAL A,eser f,ÇETINER S,Kurtaran B,TASOVA Y "Low immunity against vaccine preventable diseases in Turkish HIV cohort." Turkish Journal of Medical Sciences, 51, ss.2311 - 2317, 2021. 10.3906/sag-2102-14
ISNAD	Candevir, Aslıhan vd. "Low immunity against vaccine preventable diseases in Turkish HIV cohort". Turkish Journal of Medical Sciences 51/5 (2021), 2311-2317. https://doi.org/10.3906/sag-2102-14